Canticle Pharmaceuticals, Inc.
Other · DE · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annualNo structured XBRL financials available (common for pre-2009 filers, foreign issuers, or companies that never reported as a US public company).
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Taub RebeccaActivist (13D)Dec 12, 2025
- Friedman Paul AActivist (13D)Dec 12, 2025
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Recent SEC filings
All filings ↗- SCHEDULE 13D/ADec 12, 2025
- SCHEDULE 13D/ADec 12, 2025
- SC 13DAug 1, 2016
- SC 13DAug 1, 2016
- SC 13DJul 29, 2016
- DApr 28, 2016
- SC 13DApr 28, 2016
Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.